Why Medical Weight Loss Works Better Than Dieting for Antioch Patients

When you compare clinical trial results side by side, the advantage of medical weight loss becomes overwhelming. The STEP trials for semaglutide showed average weight loss of 14.9% of body weight over 68 weeks. The SURMOUNT trials for tirzepatide demonstrated up to 22.5% body weight reduction. By contrast, meta-analyses of commercial diet programs show average sustained weight loss of just 3-5% of body weight, with most regain occurring within two years. For an Antioch resident weighing 230 pounds, these numbers translate to real-world differences that matter. A commercial diet might help you lose 7-12 pounds that you will likely regain. Semaglutide could help you lose 34-46 pounds with medical support to maintain your results. Tirzepatide could potentially produce even greater loss. The clinical evidence is not ambiguous — medical weight loss delivers dramatically superior outcomes.

Your body has evolved sophisticated defenses against weight loss that no diet can overcome through restriction alone. When you reduce caloric intake, your hypothalamus triggers a cascade of hormonal changes: leptin (the satiety hormone) drops, ghrelin (the hunger hormone) rises, thyroid function slows, and cortisol increases. These changes can persist for years after dieting, which is why maintaining diet-induced weight loss is so extraordinarily difficult. GLP-1 medications work downstream of these defense mechanisms. By activating GLP-1 receptors in the brain, semaglutide and tirzepatide essentially override the hunger signals that would otherwise sabotage your progress. Your body still receives adequate nutrition — you simply stop receiving the false alarm signals that you are starving when you are actually well-nourished. This is why patients on GLP-1 medications can sustain weight loss that would be impossible through willpower and caloric restriction alone.

Antioch residents can access comprehensive medical weight loss at A Touch Above MedSpa in Stockton, approximately 55 minutes away via Highway 4 and I-5. While the drive is longer than some surrounding cities, patients consistently report that the quality of care and results make the trip worthwhile. Many patients schedule monthly monitoring visits and self-administer weekly injections at home between appointments. The initial consultation includes a thorough medical evaluation, BMI assessment, and discussion of your weight loss history and goals. Dr. Shailender Singh determines whether semaglutide or tirzepatide is the optimal choice based on your individual health profile. Treatment begins the same day for qualifying patients, and you leave with your first week of medication and complete instructions for self-administration.